Risici ved brug af selektive serotoningenoptagelseshæmmere til gravide

Translated title of the contribution: The risks of selective serotonin reuptake inhibitor intake in pregnancy

Terje Martens, Per Damkier, Poul Videbech

Research output: Contribution to journalJournal articleResearchpeer-review

Abstract

Depression in pregnancy is common and may have serious consequences for the mother and foetus when untreated.
In this review, we discuss selective serotonin reuptake inhibitor (SSRI) intake in pregnancy, which has been associated with increased risk of several unwanted events. However, the evidence indicating a causal relationship between the intake of SSRI in pregnancy and most investigated outcomes is of very low certainty. Confounding by indication likely accounts for most of the observed correlations. If, for any outcomes, an increased risk exists, the number needed to harm is high, and the clinical significance is unclear.
Translated title of the contributionThe risks of selective serotonin reuptake inhibitor intake in pregnancy
Original languageDanish
Article numberV06190338
JournalUgeskrift for Laeger
Volume182
Issue number5
ISSN0041-5782
Publication statusPublished - 2020

Fingerprint

Dive into the research topics of 'The risks of selective serotonin reuptake inhibitor intake in pregnancy'. Together they form a unique fingerprint.

Cite this